[0R2M] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[0R2M] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -13.44%
Quarter Report
0R2M's Result
0R2M's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 12,172,900 16,071,700 8,497,100 6,557,600 6,710,800 5,872,227 4,860,427 16.52%
PBT 4,858,800 9,325,800 3,810,400 2,429,100 2,553,500 2,078,511 1,329,815 24.09%
Tax 520,400 1,250,500 297,200 313,300 109,100 880,000 434,293 3.05%
NP 4,338,400 8,075,300 3,513,200 2,115,800 2,444,400 1,198,511 895,522 30.06%
Tax Rate -10.71% -13.41% -7.80% -12.90% -4.27% -42.34% -32.66% -
Total Cost 7,834,500 7,996,400 4,983,900 4,441,800 4,266,400 4,673,716 3,964,905 12.01%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 35.64 50.25 41.35 32.26 36.42 20.41 18.42 11.62%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 40.51 76.40 32.65 19.38 21.29 11.27 8.55 29.58%
EPS Diluted 38.22 71.97 30.52 18.46 21.29 10.34 7.70 30.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.